On 22 August, Gleneagles JPMC made history by performing its first-ever procedure using the world’s smallest heart pump.
The revolutionary Impella device supports patients with severe heart conditions, ensuring their hearts continue to beat during complex procedures.
Led by our expert cardiologists Dr Billal Patel, Dr Rajinikanth Rajagopal, and Dr Muhd Ezam Emran, the successful procedure marks a significant advancement in cardiac care for Brunei.
Dr Patel, Head of Interventional Cardiology at Gleneagles JPMC, shared, “This patient had to undergo a complex cardiac procedure. In his case, the risks were high as the patient already had weak and damaged heart muscles. With the help of the Impella device, the patient’s heart function was supported throughout, and we were able to complete the cardiac procedure successfully. The Impella device gives the doctors confidence to perform complex cases such as this one.”
With the patient now on the road to recovery, this landmark procedure sets a promising precedent for the future of cardiovascular health in our region. We are excited about the potential this technology holds for improving patient outcomes and enhancing our cardiac care capabilities.
Related Stories
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
Mount Elizabeth Hospitals Celebrate 97 Wins at Singapore Health Quality Service Awards 2026
Acibadem Powers Africa’s Premier Football Tournament
Gleneagles JPMC Supports the Children Cancer Foundation
Extending its corporate giving efforts, Gleneagles JPMC presented a cash donation of BND10,000 during its visit to the Yayasan Kanser Kanak-Kanak (YASKA).
Gleneagles Hospital Johor Opens International Lounge to Enhance Cross-border Care
